Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis

Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis

Blog Article

BackgroundThere Dog Treats is growing evidence that patients with COVID-19 are at increased risk of new-onset diabetes.The limited preliminary studies do not provide strong evidence.To assess the association of the SARS-CoV-2 virus with new-onset diabetes and to characterize the population.MethodsSearch PubMed, Embase, Cochrane Library, and Web of Science electronic databases for a limited period from December 2019 to July 2022.Two independent reviewers conducted a thorough review of eligible articles and extracted relevant information.

Pooled proportions, risk ratios (RR), and 95% confidence intervals (95% CI) indicated the incidence and risk ratios of events.ResultsThe incidence of new-onset diabetes and hyperglycemia in patients with COVID-19 was 5% (P < 0.001) (3 and 30% for new-onset diabetes and hyperglycemia, respectively), with age, ethnicity, time of diagnosis, and study type all having an impact Soccer - Clothing Junior Bottoms - Pants on the incidence (P < 0.05).New-onset diabetes and hyperglycemia were 1.

75 times higher in COVID-19 patients than in non-COVID-19 patients.In new-onset diabetes and hyperglycemia population, the percentage of men is 60% (40% for women), with a mortality rate of 17%.The proportion of new-onset diabetes and hyperglycemia after infection with COVID-19 was 25% in men and 14% in women.ConclusionsThe incidence and relative risk of new-onset diabetes and hyperglycemia are elevated after COVID-19 infection, especially in the early COVID-19 and male populations.Systemic review registrationPROSPERO registration no.

: CRD42022382989 https://www.crd.york.ac.uk/PROSPERO/display_record.

php?RecordID=382989.